Ambalal Sarabhai Enterprises Share Price

Small Cap | Pharmaceuticals and health care | BSE: 500009

₹36.74 image-0.16 (-0.43 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 37.64

High (₹) 37.64

Low (₹) 36.51

Prev. Close (₹) 36.90

Volume 1,13,700

VWAP (₹) 38.70

ROCE (%) 8.86

Industry P/E 43.95

TTM P/E 19.75

P/B Ratio 2.05

Market Cap (₹) Cr.281.55

Dividend Yield (%)--

EPS (₹) 0.74

ROE4.13%

Sales Growth (%) 1.93

Profit Growth (%)-30.88

Day Range

37.6437.64

L
H

52 Week Range

35.1077.70

L
H

Historical Returns

Returns (6M)

-42.2 %

Returns (1Y)

-20.1 %

Returns (3Y)

14.1 %

Returns (5Y)

172.15 %

Returns (6M)

-42.2 %

Returns (1Y)

-20.1 %

Returns (3Y)

14.1 %

Returns (5Y)

172.15 %

SWOT Analysis

  • Company with Low Debt
  • Book value per share improving over the last 2 years

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 26.11

MFI 13.95

ATR 3.02

Commodity Channel Index -134.62

ROC125 -39.19

ROC21 -17.86

Williams %R -91.01

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current40.3341.3042.5039.1338.1636.9635.99
Week Ago44.2445.5146.3843.3742.1041.2339.96
Month Ago46.7649.5851.1645.1842.3640.7837.96

EMA & SMA
info_icon

36.74

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 41.50


9 Day 42.72


10 Day 43.83


12 Day 45.26


14 Day 45.56

20 Day 46.79


26 Day 46.78


50 Day 50.82


100 Day 54.06


200 Day 55.74

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
TOPGAIN FINANCE PRIVATE LIMITEDbulkSell18 Jun, 2021₹34.918,47,922BSE
MONET SECURITIES PRIVATE LTDbulkSell18 Jun, 2021₹34.578,21,593BSE
ALPHA LEON ENTERPRISES LLPbulkSell18 Jun, 2021₹35.734,47,507BSE
TOPGAIN FINANCE PRIVATE LIMITEDbulkBuy18 Jun, 2021₹34.823,96,891BSE
ALPHA LEON ENTERPRISES LLPbulkBuy18 Jun, 2021₹34.154,47,507BSE
TOPGAIN FINANCE PRIVATE LIMITEDbulkSell10 Jun, 2021₹47.368,38,822BSE
TEJAS TRADEFIN LLPbulkSell10 Jun, 2021₹47.533,08,594BSE
MANSI SHARE & STOCK ADVISORS PRIVATE LIMITEDbulkSell10 Jun, 2021₹46.492,19,421BSE
TOPGAIN FINANCE PRIVATE LIMITEDbulkBuy10 Jun, 2021₹46.2119,15,316BSE
TEJAS TRADEFIN LLPbulkBuy10 Jun, 2021₹46.674,10,294BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
06 Sept, 2024Sarabhai Holdings Private LimitedAcquisition₹62.004,38,376BSE
23 Mar, 2023HARYANA CONTAINERS LIMITEDAcquisition₹22.652,000BSE
17 Mar, 2023HARYANA CONTAINERS LIMITEDAcquisition₹23.3966,000BSE
16 Mar, 2023HARYANA CONTAINERS LIMITEDAcquisition₹22.971,02,000BSE
15 Mar, 2023HARYANA CONTAINERS LIMITEDAcquisition₹22.5645,960BSE
04 Mar, 2023HARYANA CONTAINERS LIMITEDAcquisition₹24.0715,000BSE
02 Mar, 2023HARYANA CONTAINERS LIMITEDAcquisition₹24.0911,859BSE
02 Mar, 2023HARYANA CONTAINERS LIMITEDAcquisition₹23.8117,216BSE
24 Feb, 2023HARYANA CONTAINERS LIMITEDAcquisition₹24.231,00,000BSE
23 Feb, 2023HARYANA CONTAINERS LIMITEDAcquisition₹23.6035,351BSE

Corporate Actions

No corporate actions available.

Announcements

DateSourceDetail
14 Feb, 2025BSE IndiaIntegrated Filling (Financial)
14 Feb, 2025BSE IndiaWe hereby submit Financial Results (Standalone & Consolidated) for the Quarter and nine months ended 31.12.2024 along with Limited Review Report of Auditors thereon.\r\n\r\nKindly take the same on your records.
14 Feb, 2025BSE IndiaFollowing matters have been discussed, considered, and approved by the Board of Directors in its meeting held on 14th February, 2025: \r\n\r\n1. Pursuant to Regulations 30 & 33 of Chapter IV read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the Company in their meeting held on 14th February, 2025, has considered, approved and taken on record the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended on 31st December, 2024 along with Limited Review Report of Auditors thereon. \r\n\r\nIn this regard, please find enclosed herewith the following: \r\n\r\nA. Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended on 31st December, 2024; and \r\nB. Limited Review Report issued by the Statutory Auditors of the Company.\r\n\r\nKindly take the same on your records.
05 Feb, 2025BSE IndiaAMBALAL SARABHAI ENTERPRISES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we wish to inform the exchange that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 14, 2025, inter- alia, to transact the following:\r\n\r\n1. To consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter and nine months ended December 31, 2024 along with Limited Review Report of Auditors thereon.\r\n2. Any other matter as the Board of Directors of the Company may decide during the meeting.\r\n\r\nPlease take note of the same.\r\n
08 Jan, 2025BSE IndiaWe hereby submit Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the period ended 31.12.2024.\r\n\r\nKindly take the same on your records.
11 Dec, 2024BSE IndiaInauguration of Oligo Synthesis Laboratory at Ranoli Gujarat.
20 Nov, 2024BSE IndiaAnnouncement under Regulation 30 of SEBI (LODR) Regulations, 2015.\r\n\r\nKindly take note of the same.
12 Nov, 2024BSE IndiaThe Board of Directors at their meeting held on 12.11.2024 have approved financial results (Standalone and Consolidated) for the quarter and half year ended 30.09.2024 along with Limited Review Report of Auditors thereon.\r\n\r\nKindly take the same on your records.
12 Nov, 2024BSE IndiaOutcome of Board Meeting to consider and approve Standalone and Financial Results of the Company for the Quarter and Half Year ended 30.09.2024 along with Limited Review Report of the Auditors thereon.\r\n\r\nKindly take the same on your records.
04 Nov, 2024BSE IndiaAMBALAL SARABHAI ENTERPRISES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30.09.2024 along with Limited Review Report of Auditors thereon and any other matter as the Board of Directors of the Company may decide during the meeting.\r\n\r\nKindly take the same on your records.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--06 Feb, 202514 Feb, 2025
Quarterly Results--05 Nov, 202412 Nov, 2024
Quarterly Results--02 Aug, 202409 Aug, 2024
Audited Results--20 May, 202424 May, 2024
Quarterly Results--06 Feb, 202413 Feb, 2024
Quarterly Results--31 Oct, 202307 Nov, 2023
A.G.M.--17 Aug, 202319 Aug, 2023
Quarterly Results--17 Aug, 202310 Aug, 2023
Audited Results--24 May, 202330 May, 2023
Quarterly Results--07 Feb, 202310 Feb, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameSept, 2024Jun, 2024Mar, 2024Dec, 2023Sept, 2023

About Ambalal Sarabhai Enterprises

Ambalal Sarabhai Enterprises is a Public Limited Listed company incorporated on 05/06/1978 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L52100GJ1978PLC003159 and registration number is 003159. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 3.81 Cr. and Equity Capital is Rs. 76.63 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Sarabhai Enterprises Group

Founded

1978

Managing Director

Mr. Mohal K Sarabhai

NSE Symbol

--

Ambalal Sarabhai Enterprises Management

NameDesignation
Mr. Kartikeya V SarabhaiExecutive Chairman
Mr. Mohal K SarabhaiManaging Director
Ms. Chaula M ShastriWhole Time Director
Dr. Pushpa RobinIndependent Director
Mr. Mayur K SwadiaIndependent Director
Mr. Satyen DaveIndependent Director
Mr. Brijesh KhandelwalIndependent Director
Mr. Govindprasad NamdeoIndependent Director
Mr. Ajay MayorNominee Director
Mr. Bharatendu JaniNominee Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on Ambalal Sarabhai Enterprises

What is the share price of Ambalal Sarabhai Enterprises?

The share price of Ambalal Sarabhai Enterprises on 13 Mar, 2025 is ₹ 36.74.

What is 52W high and 52W low share price of Ambalal Sarabhai Enterprises?

The highest and lowest 52W share prices of Ambalal Sarabhai Enterprises are ₹ 77.700 and ₹ 35.100

What is the market cap of Ambalal Sarabhai Enterprises?

The market capitalization of Ambalal Sarabhai Enterprises as of 13 Mar, 2025 is ₹ 281.55 Crores

What is the P/E ratio of Ambalal Sarabhai Enterprises?

The current P/E ratio of Ambalal Sarabhai Enterprises as of 13 Mar, 2025 is 43.95

What is the PB ratio of Ambalal Sarabhai Enterprises?

The PB ratio of Ambalal Sarabhai Enterprises as of 13 Mar, 2025 is 2.05

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited